Suppr超能文献

腹腔镜与开腹手术治疗老年病理性 TNM 期胃癌的匹配研究。

Laparoscopic versus opengastric surgery for the treatment of pathological TNM gastric cancer in elderly patients: a matched study.

机构信息

School of Public Health, Guangdong Medical University, Dongguan, 523808, Guangdong, PR China.

Department of Chemotherapy, The People's Hospital of Gaozhou, Gaozhou, 525200, Guangdong, PR China.

出版信息

Sci Rep. 2017 May 15;7(1):1919. doi: 10.1038/s41598-017-02182-5.

Abstract

The aim of this study was to compare the outcomes of laparoscopic surgery (LAP) and open gastric surgery (OP) in early gastric cancer patients aged ≥70 years.We conducted a retrospectively analysis among patientswith pathological TNM gastric cancer,who underwent LAP or OP between January 1, 2001 and December 31, 2008. We identified a well-balanced cohort of 2,360 patients (1180 patients in each group). LAP has been shown to offer a superior perioperative results to OP, including lower blood loss, shorter time to oral intake, walk and bowel function recovery, shorter time of hospital stay, and less blood transfusion required. However, the intraoperative and postoperative complications, local recurrence, and metastasis didn't show statistically significant differences between groups. The 5-year overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS) were 60.1% vs.63.2%, 80.8% vs. 83.3%, and 87.6% vs. 89.5% in the LAP group and OP group, respectively. The hazard ratios (HR) for OS, DFS, and CSS were 1.09(95% confidence interval [CI]: 0.95-1.25; P = 0.215), 1.03(95% CI: 0.91-1.18; P = 0.636), and 1.07 (95% CI: 0.88-1.30; P = 0.484), respectively, compared LAP group with OP group. In conclusion, LAP is an acceptable alternative to OP in elderly patients with early gastric cancer.

摘要

本研究旨在比较腹腔镜手术(LAP)和开腹胃手术(OP)治疗≥70 岁早期胃癌患者的结局。我们对 2001 年 1 月 1 日至 2008 年 12 月 31 日期间接受 LAP 或 OP 的病理 TNM 胃癌患者进行了回顾性分析。我们确定了一个均衡的队列,共 2360 例患者(每组 1180 例)。与 OP 相比,LAP 具有更优的围手术期结果,包括出血量更少、开始口服饮食的时间更早、胃肠功能恢复更快、住院时间更短以及需要输血的患者更少。然而,两组患者的术中术后并发症、局部复发和转移无统计学差异。LAP 组和 OP 组的 5 年总生存率(OS)、无病生存率(DFS)和癌症特异性生存率(CSS)分别为 60.1% vs. 63.2%、80.8% vs. 83.3%和 87.6% vs. 89.5%。OS、DFS 和 CSS 的风险比(HR)分别为 1.09(95%置信区间 [CI]:0.95-1.25;P=0.215)、1.03(95% CI:0.91-1.18;P=0.636)和 1.07(95% CI:0.88-1.30;P=0.484),LAP 组与 OP 组相比。综上所述,LAP 是老年早期胃癌患者的一种可接受的 OP 替代治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3974/5432525/a40d29b13abc/41598_2017_2182_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验